Drug Information

Drug General Information
Drug ID
D08XPW
Former ID
DNC005608
Drug Name
CYTISINE
Drug Type
Small molecular drug
Indication Discovery agent Investigative [540784]
Structure
Download
2D MOL

3D MOL
Formula
C11H14N2O
InChI
InChI=1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-6-9)7-13(10)11/h1-3,8-9,12H,4-7H2/t8-,9+/m0/s1
InChIKey
ANJTVLIZGCUXLD-DTWKUNHWSA-N
PubChem Compound ID
10235
PubChem Substance ID
589961, 8157380, 10321241, 11112361, 11113087, 11114058, 15899404, 16325148, 22390246, 26752181, 29204005, 29228756, 47434815, 47434816, 48179676, 48253910, 49698590, 49833166, 49960142, 50124228, 56463106, 57326061, 74570465, 76715582, 85148349, 85787849, 88528961, 103654654, 104032478, 104121483, 104253548, 104322739, 104825241, 117673734, 118867704, 121363225, 124757690, 124801290, 124882289, 124882290, 124882291, 125164494, 126594023, 126688798, 134342813, 134975346, 135544049, 136187309, 137248536, 151972521
Target and Pathway
Target(s) Neuronal acetylcholinereceptor subunit alpha-2 Target Info Inhibitor [528157]
Neuronal acetylcholine receptor protein, alpha-4 chain Target Info Inhibitor [528394]
Neuronal acetylcholine receptor protein, beta-4 chain Target Info Inhibitor [529383]
Neuronal acetylcholine receptor protein, beta-2 chain Target Info Inhibitor [528394]
Neuronal acetylcholine receptor protein, alpha-7 chain Target Info Inhibitor [527753]
KEGG Pathway Neuroactive ligand-receptor interactionhsa04080:Neuroactive ligand-receptor interaction
Cholinergic synapse
Nicotine addictionhsa04080:Neuroactive ligand-receptor interaction
Cholinergic synapsehsa04080:Neuroactive ligand-receptor interaction
Nicotine addictionhsa04020:Calcium signaling pathway
Neuroactive ligand-receptor interaction
Nicotine addiction
Chemical carcinogenesis
PANTHER Pathway Nicotinic acetylcholine receptor signaling pathwayP00044:Nicotinic acetylcholine receptor signaling pathway
Nicotine pharmacodynamics pathwayP00044:Nicotinic acetylcholine receptor signaling pathway
Nicotine pharmacodynamics pathwayP00003:Alzheimer disease-amyloid secretase pathway
Nicotinic acetylcholine receptor signaling pathway
Reactome Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
Highly calcium permeable nicotinic acetylcholine receptorsR-HSA-629587:Highly sodium permeable acetylcholine nicotinic receptors
Highly calcium permeable nicotinic acetylcholine receptorsR-HSA-629594:Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
WikiPathways Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic CellWP706:SIDS Susceptibility Pathways
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
Nicotine Activity on Dopaminergic NeuronsWP706:SIDS Susceptibility Pathways
Nicotine Activity on Chromaffin CellsWP706:SIDS Susceptibility Pathways
References
Ref 540784(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5347).
Ref 527753Bioorg Med Chem Lett. 2005 Nov 15;15(22):4889-97.3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation.
Ref 528157J Med Chem. 2006 May 4;49(9):2673-6.Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
Ref 528394Bioorg Med Chem Lett. 2006 Nov 1;16(21):5493-7. Epub 2006 Aug 28.Epibatidine isomers and analogues: structure-activity relationships.
Ref 529383Bioorg Med Chem Lett. 2008 Apr 1;18(7):2316-9. Epub 2008 Mar 6.Deconstructing cytisine: The syntheses of (+/-)-cyfusine and (+/-)-cyclopropylcyfusine, fused ring analogs of cytisine.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.